Goodwin Procter assisted FemHealth Ventures on the matter. FemHealth Ventures, which invests in companies focused on women’s health, has closed a $32 million debut fund despite...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Alladapt Immunotherapeutics Inc. on the deal. Alladapt Immunotherapeutics Inc. announced its $100+ million financing round led by Enavate Sciences, a portfolio company created by...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised AbCellera on the deal. AbCellera (Nasdaq: ABCL) announced its acquisition of TetraGenetics. AbCellera is a technology company with a centralized operating system for next-generation...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Kriya Therapeutics on the deal, while Kirkland & Ellis advised Patient Square Capital. Kriya Therapeutics announced the closing of a $100 Million Series...
You must be a Standard 1 Year member to access this content.
